Literature DB >> 4092169

High prevalence of myopia among young adult Yupik Eskimos.

W L Alward, T R Bender, J A Demske, D B Hall.   

Abstract

Myopia is common in Western populations but is considered rare in nonindustrialized population groups. However, studies in undeveloped areas of the Arctic and sub-Arctic have demonstrated increased rates of myopia among young Inuit adults indigenous to the region. We examined the refractive status of Yupik Eskimos, a group that had not previously been evaluated. Our subjects were young adults born between November 1960 and December 1962 to persons living in 10 villages in southwestern Alaska. The refractive status was obtained for 92% of these persons. The prevalence of myopia (refractive error -0.50 D or greater) was 68%, a rate among the highest reported for a general population anywhere in the world. The young women were significantly more myopic than the young men (mean refractive errors -1.91 and -1.36 D respectively). Astigmatism and myopia were positively correlated (r = 0.20, p less than 0.01). The etiology of myopia in this population is under study.

Entities:  

Mesh:

Year:  1985        PMID: 4092169

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN: 0008-4182            Impact factor:   1.882


  4 in total

1.  The effect of two-zone concentric bifocal spectacle lenses on refractive error development and eye growth in young chicks.

Authors:  Yue Liu; Christine Wildsoet
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-02-22       Impact factor: 4.799

2.  Progression of myopia.

Authors:  R H Kennedy
Journal:  Trans Am Ophthalmol Soc       Date:  1995

3.  Astigmatism in monkeys with experimentally induced myopia or hyperopia.

Authors:  Chea-Su Kee; Li-Fang Hung; Ying Qiao-Grider; Ramkumar Ramamirtham; Earl L Smith
Journal:  Optom Vis Sci       Date:  2005-04       Impact factor: 1.973

4.  Astigmatism in Chinese preschool children: prevalence, change, and effect on refractive development.

Authors:  D S P Fan; S K Rao; E Y Y Cheung; M Islam; S Chew; D S C Lam
Journal:  Br J Ophthalmol       Date:  2004-07       Impact factor: 4.638

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.